These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 34378321

  • 1. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
    Zhang B, Chan SH, Liu XQ, Shi YY, Dong ZX, Shao XR, Zheng LY, Mai ZY, Fang TL, Deng LZ, Zhou DS, Chen SN, Li M, Zhang XD.
    J Cell Mol Med; 2021 Sep; 25(18):8836-8849. PubMed ID: 34378321
    [Abstract] [Full Text] [Related]

  • 2. TWIST1 Promotes Colorectal Carcinoma Stemness and Oxaliplatin Resistance by Activating Microfibrillar-Associated Protein 2.
    Liu Y, Chen M, Wu B.
    Assay Drug Dev Technol; 2023 Jul; 21(5):202-211. PubMed ID: 37428562
    [Abstract] [Full Text] [Related]

  • 3. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
    Shen X, Hu X, Mao J, Wu Y, Liu H, Shen J, Yu J, Chen W.
    Cell Death Dis; 2020 Jan 27; 11(1):65. PubMed ID: 31988275
    [Abstract] [Full Text] [Related]

  • 4. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J, Yuan W, Wu L, Tang Q, Xia Q, Ji J, Liu Z, Ma Z, Zhou Z, Cheng Y, Shu X.
    Oncotarget; 2017 Feb 07; 8(6):9961-9973. PubMed ID: 28035069
    [Abstract] [Full Text] [Related]

  • 5. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G, Di Caro G, Bianchi P, Grizzi F, Basso G, Marchesi F, Doni A, Marra G, Roncalli M, Mantovani A, Malesci A, Laghi L.
    Gastroenterology; 2013 Sep 07; 145(3):647-57.e15. PubMed ID: 23684708
    [Abstract] [Full Text] [Related]

  • 6. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
    Shi T, Ma Y, Cao L, Zhan S, Xu Y, Fu F, Liu C, Zhang G, Wang Z, Wang R, Lu H, Lu B, Chen W, Zhang X.
    Cell Death Dis; 2019 Apr 05; 10(4):308. PubMed ID: 30952834
    [Abstract] [Full Text] [Related]

  • 7. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y, Han T, Zhang T, Ma C, Sun C.
    Oncotarget; 2017 May 30; 8(22):36410-36422. PubMed ID: 28430582
    [Abstract] [Full Text] [Related]

  • 8. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y, Jiang H, Li W, Chen L, Zhu W, Xian Y, Han Z, Yin L, Liu Y, Wang Y, Pan K, Zhang K.
    Aging (Albany NY); 2020 Dec 03; 12(23):24424-24440. PubMed ID: 33291076
    [Abstract] [Full Text] [Related]

  • 9. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
    Yusup A, Huji B, Fang C, Wang F, Dadihan T, Wang HJ, Upur H.
    World J Gastroenterol; 2017 Jan 07; 23(1):110-120. PubMed ID: 28104986
    [Abstract] [Full Text] [Related]

  • 10. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
    Zhang C, Zeng M, Xu Y, Huang B, Shi P, Zhu X, Cao Y.
    Gene; 2024 Jul 01; 914():148406. PubMed ID: 38521111
    [Abstract] [Full Text] [Related]

  • 11. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y, Chan S, Chen S, Liu X, Li M, Zheng L, Dong Z, Yang Z, Liu Z, Zhou D, Zhang X, Zhang B.
    J Transl Med; 2024 Feb 03; 22(1):133. PubMed ID: 38310229
    [Abstract] [Full Text] [Related]

  • 12. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer.
    Xiao Z, Liu Y, Li Q, Liu Q, Liu Y, Luo Y, Wei S.
    Cancer Chemother Pharmacol; 2021 Dec 03; 88(6):1021-1031. PubMed ID: 34599680
    [Abstract] [Full Text] [Related]

  • 13. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
    Lu K, Dong JL, Fan WJ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 03; 22(23):8210-8219. PubMed ID: 30556860
    [Abstract] [Full Text] [Related]

  • 14. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY, Zhang M, Cong Q, Zhang MX, Zhang MY, Lu YY, Xu CJ.
    Int J Biochem Cell Biol; 2018 Feb 03; 95():9-16. PubMed ID: 29247711
    [Abstract] [Full Text] [Related]

  • 15. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
    Cheng C, Xie Z, Li Y, Wang J, Qin C, Zhang Y.
    Biomed Pharmacother; 2018 Dec 03; 108():194-200. PubMed ID: 30219676
    [Abstract] [Full Text] [Related]

  • 16. Aminopeptidase A initiates tumorigenesis and enhances tumor cell stemness via TWIST1 upregulation in colorectal cancer.
    Chuang HY, Jiang JK, Yang MH, Wang HW, Li MC, Tsai CY, Jhang YY, Huang JC.
    Oncotarget; 2017 Mar 28; 8(13):21266-21280. PubMed ID: 28177885
    [Abstract] [Full Text] [Related]

  • 17. LncRNA-NEF suppressed oxaliplatin resistance and epithelial-mesenchymal transition in colorectal cancer through epigenetically inactivating MEK/ERK signaling.
    Shi CJ, Xue ZH, Zeng WQ, Deng LQ, Pang FX, Zhang FW, Fu WM, Zhang JF.
    Cancer Gene Ther; 2023 Jun 28; 30(6):855-865. PubMed ID: 36782047
    [Abstract] [Full Text] [Related]

  • 18. Silencing of E-cadherin expression leads to increased chemosensitivity to irinotecan and oxaliplatin in colorectal cancer cell lines.
    Skarkova V, Skarka A, Manethova M, Stefanidi AA, Rudolf E.
    Hum Exp Toxicol; 2021 Dec 28; 40(12):2063-2073. PubMed ID: 34075792
    [Abstract] [Full Text] [Related]

  • 19. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou X, Zhang ZJ, Peng YH, Yang YZ, Yun JP.
    Carcinogenesis; 2014 Feb 28; 35(2):469-78. PubMed ID: 24085799
    [Abstract] [Full Text] [Related]

  • 20. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1.
    Zhou Y, He A, Zhang L, Yi G.
    Neoplasma; 2020 Mar 28; 67(2):296-303. PubMed ID: 31884801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.